Eagle Indo Pharma is primarily engaged in medicinals and botanicals activity. Its headquarters is located in Banten. The company was founded in 1973. Eagle Indo Pharma, also known as Cap Lang, was founded by Mr. Handojo Santosa. The company has established itself as a prominent player in the pharmaceutical industry in Indonesia, focusing on the production and distribution of over-the-counter (OTC) medications and herbal products. Its primary business line is the manufacturing of medicinals, with a secondary focus on botanicals. The company operates several branches across Indonesia, ensuring a strong local geographical footprint. Eagle Indo Pharma's main product types include topical analgesics, herbal supplements, and traditional medicines. Some of its well-known product brands are Cap Lang Minyak Kayu Putih, Cap Lang Balsem Otot Geliga, and Cap Lang Minyak Telon. While the company primarily serves the Indonesian market, it has also expanded its reach to several countries in Southeast Asia, contributing to its global geographical footprint. Eagle Indo Pharma collaborates with various local and international partners to enhance its product offerings and market reach. The company is a member of several pharmaceutical and herbal industry associations, which helps it stay updated with industry trends and regulations. Eagle Indo Pharma is committed to maintaining high-quality standards in its products and operations, aiming to improve the health and well-being of its consumers. With a focus on innovation and customer satisfaction, Eagle Indo Pharma's mission is to provide effective and affordable healthcare solutions, while its vision is to be a leading pharmaceutical company in the region, known for its trusted and reliable products.
Headquarters
RT 001 RW 004
Tangerang; Banten;
Postal Code: 15133
Contact Details: Purchase the PT Eagle Indo Pharma report to view the information.
Website: http://www.caplang.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service